小细胞肺癌：靶点概述

数据集获取（Figshare）

• 源站标题：Small cell lung cancer: an overview of the targets
• DOI：10.6084/m9.figshare.19899389.v1
• 发布日期：2022-05-27
• 文件数：6 个
• 文件总体积：2.93 MB
• 源站页面：https://scielo.figshare.com/articles/dataset/Small_cell_lung_cancer_an_overview_of_the_targets/19899389

命令行下载

curl -L -o "3e47e1993cca7335bcc3c43bc09ddbbb8f600a1f.tif" "https://ndownloader.figshare.com/files/35323052"
curl -L -o "1d3fbb7e5d0d2be33ea0ca3d059c2669a15599d4.png" "https://ndownloader.figshare.com/files/35323055"
curl -L -o "fd04c8fd2502c79111233791847e6c32fa1c702f.jpg" "https://ndownloader.figshare.com/files/35323058"
curl -L -o "1cf8a42dca36363eb8175bcdebdb9c981d0e32b5.tif" "https://ndownloader.figshare.com/files/35323061"
curl -L -o "6ecaf8f44017c93a5b7faf25a9b1d42089184b80.png" "https://ndownloader.figshare.com/files/35323064"
curl -L -o "112c96343ccfb081e2bc636ea62569deb41e8354.jpg" "https://ndownloader.figshare.com/files/35323067"

文件清单

• 3e47e1993cca7335bcc3c43bc09ddbbb8f600a1f.tif（1.04 MB）
• 1d3fbb7e5d0d2be33ea0ca3d059c2669a15599d4.png（87.04 KB）
• fd04c8fd2502c79111233791847e6c32fa1c702f.jpg（5.41 KB）
• 1cf8a42dca36363eb8175bcdebdb9c981d0e32b5.tif（1.57 MB）
• 6ecaf8f44017c93a5b7faf25a9b1d42089184b80.png（219.40 KB）
• 112c96343ccfb081e2bc636ea62569deb41e8354.jpg（6.65 KB）

文件总体积 2.93 MB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Abstract Lung cancer is the leading cause of cancer deaths worldwide. Small cell lung cancer (SCLC) accounts for approximately 15% of all lung cancer cases. Despite a frequently good response to first-line treatment with chemotherapy and/or radiotherapy, early relapse occurs in the majority of patients and 5-year survival is only about 5%. This histological subtype of lung cancer is strongly associated with tobacco smoking. The behavior of SCLC is unique within solid tumors. Initially, it positively responds to chemotherapy or radiotherapy. However, at relapse, which occurs early in the majority of cases, the tumor is resistant to available therapy and eventually will cause the death of the patient. These results in an overall 5-year survival of approximately 5% for the entire population of patients diagnosed with SCLC. This dismal prognosis has not significantly changed in past years. There is an urgent need for discovery targets to select patients more prone to having a proper response to the treatment, avoiding to reduce their resistance and resulting the increase of overall and progression-free survivals.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.19899389.v1（source: https://scielo.figshare.com/articles/dataset/Small_cell_lung_cancer_an_overview_of_the_targets/19899389）。